During the past decade, Cancer Care Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Associates" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Point Therapeutics" with 3 trials sponsored, "Agennix" with 2 trials sponsored, "Millennium Pharmaceuticals, Inc." with 2 trials sponsored and "Novartis Pharmaceuticals" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Associates" #1 collaborator was "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Associates" are "Prostate Cancer" (3 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Cancer Care Associates" in a lesser frequency.

Most popular intervention types in "Cancer Care Associates" are "Drug" (35 trials), "Other" (11 trials), "Biological" (9 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Bevacizumab" (7 trials), "Paclitaxel" (7 trials), "Carboplatin" (6 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Associates" are 30 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Care Associates". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Cancer Care Associates, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Associates, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".